In conclusion, our study demonstrates that TOPK is a key mediator in LPS/TLR4 signaling to trigger breast cancer invasion, and that LPS/TLR4 signaling enhances expression and activity of TOPK leading to NF-κB activation, thereby enhancing MMP9 expression and subsequent breast cancer cell invasion. The gene discussed is MMP9; the disease is breast carcinoma.